Accuneb and Radiculitis lumbosacral - a phase IV clinical study of FDA data

Summary:

Radiculitis lumbosacral is reported as a side effect among people who take Accuneb (albuterol sulfate), especially for people who are male, 60+ old, also take Celebrex, and have Metastases to bone.

The phase IV clinical study analyzes which people have Radiculitis lumbosacral when taking Accuneb. It is created by eHealthMe based on reports of 187 people who have side effects when taking Accuneb from the FDA, and is updated regularly.

What is Accuneb?

Accuneb has active ingredients of albuterol sulfate. eHealthMe is studying from 189 Accuneb users. Check the latest studies of Accuneb.

What is Radiculitis lumbosacral?

Radiculitis lumbosacral (inflammation of nerve root at labosacral vertebrea) is found to be associated with 113 drugs and 164 conditions by eHealthMe. Check the latest studies of Radiculitis lumbosacral.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

187 people reported to have side effects when taking Accuneb.
Among them, 12 people (6.42%) have Radiculitis lumbosacral.

Could Accuneb cause Radiculitis lumbosacral?

Among these 12 people:

What is the gender of people who have Radiculitis lumbosacral when taking Accuneb? *

female: 8.33 %
male: 91.67 %

What is the age of people who have Radiculitis lumbosacral when taking Accuneb? *

What are other drugs people take besides Accuneb? *

What are other side effects people have besides Radiculitis lumbosacral? *

Weakness: 12 people, 100.00%
Spinal Column Stenosis (narrowing of spinal column): 12 people, 100.00%
Back Pain: 12 people, 100.00%
Bone Density Decreased: 12 people, 100.00%
Cyst (a closed sac): 12 people, 100.00%
Jaw Disorder (jaw disease): 12 people, 100.00%
Joint Effusion (presence of extra fluid in joint covering): 12 people, 100.00%
Joint Injury: 12 people, 100.00%
Metastases To Bone (cancer spreads to bone): 12 people, 100.00%
Pain: 12 people, 100.00%

What are the existing conditions these people have? *

Sleep Disorder: 12 people, 100.00%
Metastases To Bone (cancer spreads to bone): 12 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Accuneb and have Radiculitis lumbosacral?

- Check whether Radiculitis lumbosacral is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Accuneb:

Accuneb (189 reports)

Browse all side effects of Accuneb:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Radiculitis lumbosacral:

Radiculitis lumbosacral (113 drugs)

Browse all the conditions that are associated with Radiculitis lumbosacral:

Radiculitis lumbosacral (164 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate (the active ingredients of Accuneb) and Accuneb (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.